Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04639297 · ClinicalTrials.gov registry record · NA
NeuroVision vs Standard Neuromonitoring
A NA study of Neurologic Deficits, sponsored by Rush University Medical Center.
- Recruiting
- Registry status
- NA
- Development phase
- 148
- Enrollment target
- 1
- Study location
NCT04639297: Recruiting NA study of Neurologic Deficits, sponsored by Rush University Medical Center.
NCT04639297 is a NA study of Neurologic Deficits that is actively recruiting participants, run by Rush University Medical Center. The registered enrollment target is 148 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04639297, a NA study of Neurologic Deficits, is actively recruiting participants, sponsored by Rush University Medical Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 148 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to perform a prospective, randomized, controlled clinical trial to assess the utility of IONM in patients undergoing primary, single or multilevel lateral spinal procedures. Subjects will be randomized to undergo a lateral spine surgery with the use of NeuroVision® IONM or conventional hospital based IONM to assess incidence of new-onset neurological injury.
Primary Outcome
Decreased somatosensory evoked potentials (SSEP) and transcranial MEPs (tcMEPs)
Conditions Studied
Interventions
- DEVICE NeuroVision® IONM
- DEVICE Hospital Based IONM
Study Locations (1)
Illinois
- Rush University Medical Center - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 148 participants |
| Start Date | 2020-09-28 |
| Est. Completion | 2027-06-20 |
| Phase | NA |
What NCT04639297 shows while recruiting
NCT04639297 is an interventional study that assigns participants to a tested intervention. The registered 148 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower).
The record links to 1 condition, with Neurologic Deficits appearing as the primary indexed condition, and to 2 interventions - of which NeuroVision® IONM is the first listed.
NCT04639297 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT04639297 about?
NCT04639297 is a clinical study titled "NeuroVision vs Standard Neuromonitoring". The purpose of this study is to perform a prospective, randomized, controlled clinical trial to assess the utility of IONM in patients undergoing primary, single or multilevel lateral spinal procedures. Subjects will be randomized to undergo a lateral spine surgery with the use of NeuroVision® IONM ...
What is the current status of trial NCT04639297?
This trial is currently recruiting. It is a NA study. The enrollment target is 148 participants. The study started on 2020-09-28. Estimated completion is 2027-06-20.
What conditions does trial NCT04639297 study?
This clinical trial studies the following conditions: Neurologic Deficits.
What interventions are being tested in trial NCT04639297?
The interventions under investigation include: NeuroVision® IONM (DEVICE), Hospital Based IONM (DEVICE).
Who is sponsoring clinical trial NCT04639297?
This trial is sponsored by Rush University Medical Center, which has 320 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04639297 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Neurologic Deficits
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04639297's enrollment target sits among peer trials
148 702nd of 2000 higher than 1,298 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00739362 · 148 participants · Phase 2
Effects of Brain Stimulation on Food Intake and Behavioral Weight Loss Treatment
- NCT03161223 · 148 participants · Phase 1
Durvalumab in Different Combinations With Pralatrexate, Romidepsin and Oral 5-Azacitidine for Lymphoma
- NCT03858231 · 148 participants · Phase 4
Opioids Versus Non-Opioids Postoperative After Knee Arthroscopic Surgery
- NCT04486352 · 148 participants · Phase 1
A Study of Targeted Agents for Patients With Recurrent or Persistent Endometrial Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI